JBCHEPHARM.BOJBCHEPHARM.BOBSE
Loading
EBITDA Margin Over TimeStable
Percentile Rank79
3Y CAGR+3.2%
5Y CAGR+1.9%
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

3Y CAGR
+3.2%/yr
vs +7.0%/yr prior
5Y CAGR
+1.9%/yr
Consistent
Acceleration
-3.8pp
Decelerating
Percentile
P79
Within normal range
vs 5Y Ago
1.1x
Modest growth
Streak
1 yr
Consecutive declineStable
PeriodValueYoY Change
202526.34%-1.7%
202426.79%+18.5%
202322.60%-5.8%
202223.99%-28.4%
202133.51%+39.6%
202024.01%+11.6%
201921.51%+17.5%
201818.31%-14.5%
201721.42%-5.3%
201622.61%-